ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,612 | +38.7% | 2,100 | 0.0% | 0.00% | – |
Q2 2022 | $2,604 | +90.1% | 2,100 | 0.0% | 0.00% | – |
Q1 2022 | $1,370 | -40.1% | 2,100 | 0.0% | 0.00% | – |
Q4 2021 | $2,289 | -40.1% | 2,100 | 0.0% | 0.00% | – |
Q3 2021 | $3,822 | -19.6% | 2,100 | +16.7% | 0.00% | – |
Q2 2021 | $4,752 | -26.7% | 1,800 | 0.0% | 0.00% | – |
Q1 2021 | $6,480 | +97.8% | 1,800 | +38.5% | 0.00% | – |
Q4 2020 | $3,276 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q3 2020 | $3,276 | -23.2% | 1,300 | 0.0% | 0.00% | – |
Q2 2020 | $4,264 | +33.9% | 1,300 | 0.0% | 0.00% | – |
Q1 2020 | $3,185 | -48.1% | 1,300 | 0.0% | 0.00% | – |
Q4 2019 | $6,136 | +10.3% | 1,300 | 0.0% | 0.00% | – |
Q3 2019 | $5,564 | -26.8% | 1,300 | -0.3% | 0.00% | -100.0% |
Q2 2019 | $7,602 | +51.4% | 1,304 | 0.0% | 0.00% | – |
Q1 2019 | $5,020 | +105.9% | 1,304 | 0.0% | 0.00% | – |
Q4 2018 | $2,438 | +18653.8% | 1,304 | +32500.0% | 0.00% | – |
Q3 2018 | $13 | +8.3% | 4 | 0.0% | 0.00% | – |
Q2 2018 | $12 | -25.0% | 4 | 0.0% | 0.00% | – |
Q1 2018 | $16 | -5.9% | 4 | 0.0% | 0.00% | – |
Q4 2017 | $17 | – | 4 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |